| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Fels Research Institute and the Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 [F. A. F., J. B. S., S. W.], and the Department of Biochemistry, Howard University School of Medicine, Washington, D. C. 20001 [H. P. M.]
Pyruvate kinase (PK) (EC 2.7.1.40
Although one highly differentiated hepatoma, 9618A, has a PK isozyme pattern similar to that of liver, other well- and highly differentiated hepatomas had much lower total activities than liver, with a preponderance of PK III. In contrast, the rapidly growing, poorly differentiated hepatomas had extremely high total PK activity, virtually all consisting of PK III. These results provide further evidence of a profound alteration of gene expression in hepatomas resulting in the loss of a specific liver-marker isozyme with loss of differentiation and its replacement in poorly differentiated hepatomas by high activities of an isozyme normally very low in the normal liver.
1 This work was aided by Grants CA-10729, CA-10916, and CA-12226 from the National Cancer Institute, and by Grant BC-74 from the American Cancer Society.
2 Part of this work was taken from a thesis submitted to the Graduate Council of Temple University, June 1970, in partial fulfillment of the requirements for the Ph.D. degree. Present address: Department of Clinical Chemistry, Temple University Hospital.
Received 10/23/73.
Accepted 3/ 7/74.
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Copyright © 1974 by the American Association for Cancer Research.
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online